Literature DB >> 2040013

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation.

J Milner1, E A Medcalf.   

Abstract

Activating mutations of p53 promote tumor progression. The mutant protein adopts a characteristic conformation, which lacks the growth suppressor function of wild-type p53. We show that mutant p53 can drive cotranslated wild-type p53 into the mutant conformation: a similar effect in vivo would block wild-type suppressor function with dominant negative effect. The cotranslational effect of mutant p53 on wild-type conformation depends upon interaction between nascent polypeptides and oligomerization of the full-length proteins. We also show that oligomers of p53 proteins can be induced to change conformation in a cooperative manner. Cell growth stimulation induces a similar conformational change in p53, and our present results indicate that this may involve allosteric regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040013     DOI: 10.1016/0092-8674(91)90384-b

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  177 in total

Review 1.  Demystified ... p53.

Authors:  S J Darnton
Journal:  Mol Pathol       Date:  1998-10

2.  Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.

Authors:  Rajan Gogna; Esha Madan; Periannan Kuppusamy; Uttam Pati
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium.

Authors:  D T Tan; W Y Tang; Y P Liu; H S Goh; D R Smith
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

4.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

5.  Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein.

Authors:  J Baudier; C Delphin; D Grunwald; S Khochbin; J J Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

7.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

8.  TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.

Authors:  Apostolos Klinakis; Theodoros Rampias
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

9.  An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele.

Authors:  T Nakamura; J G Pichel; L Williams-Simons; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.